Sharon Bio-Medicine Ltd. (India)

Sharon Bio-Medicine Limited operates in the pharmaceutical sector of India which primarily offers active pharmaceutical ingredients (API), pellets, and intermediates. The company's API product line targets cardiovascular, anti depressant, anti malarial, skeletal muscle relaxant, veterinary, anti dopaminergic, anti Alzheimer, anti histamine, anti fungal, anti diabetic, anti convulsant, anti diarrhoeal, anti Parkinson, and erectile dysfunction therapeutic categories. Its pellets product line targets anti-ulcerative and anti-fungal therapeutic categories; and intermediate product line targets various API/end uses, including ketoconazole, itraconazole, phase transfer catalyst, omeprazole, lansoprazole, sparfloxacin, organic synthesis, agro chemical, pantaprazole, trimetazidine, lamotrigine, ezetimibe, sertraline, imatinib, and losarton potassium. The company also offers formulations comprising general products, oncology product line, and cephalosporins and beta-lactums in tablet, capsule, and injection forms. Sharon Bio-Medicine Limited markets its products in India, Latin America, the Middle East, south east Asia, and Africa, as well as in SAARC countries. The company is based in Navi Mumbai, India